Q3 2024 Holdings
Filed 2024-11-14 | 71 holdings | $3.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $385.3K | 48,100 | 0.0% |
| Metagenomi Inc(MGX) | COM | 59102M104 | $667.3K | 307,500 | 0.0% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $1.8M | 828,485 | 0.1% |
| Aligos Therapeutics Inc(ALGS) | COM NEW | 01626L204 | $2.1M | 244,110 | 0.1% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $2.2M | 674,833 | 0.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $2.3M | 140,000 | 0.1% |
| Neumora Therapeutics Inc.(NMRA)Call | COM | 640979100 | $2.4M | 180,500 | 0.1% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $2.5M | 219,648 | 0.1% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $3.3M | 5,000,000 | 0.1% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $5.1M | 3,262,564 | 0.2% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $5.3M | 1,553,996 | 0.2% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $7.4M | 531,857 | 0.2% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $7.5M | 567,428 | 0.2% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $9.2M | 967,000 | 0.3% |
| Inovio Pharmaceuticals Inc(INO) | COM SHS | 45773H409 | $10.4M | 1,804,366 | 0.3% |
| Eliem Therapeutics Inc(CLYM) | COM | 28658R106 | $11.0M | 2,169,143 | 0.4% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $11.2M | 10,953,937 | 0.4% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $13.3M | 3,283,783 | 0.4% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $13.6M | 1,529,987 | 0.4% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $14.5M | 7,419,355 | 0.5% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $15.4M | 4,184,100 | 0.5% |
| Xencor Inc(XNCR) | COM | 98401F105 | $16.1M | 800,000 | 0.5% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $16.7M | 4,900,334 | 0.5% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $17.2M | 2,607,633 | 0.5% |
| Axsome Therapeutics Inc(AXSM)Call | COM | 05464T104 | $18.0M | 200,000 | 0.6% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $18.2M | 1,000,000 | 0.6% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $19.5M | 5,572,607 | 0.6% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $19.8M | 689,784 | 0.6% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $20.3M | 796,852 | 0.6% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $20.5M | 2,766,512 | 0.6% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $20.7M | 15,922,655 | 0.7% |
| Alector Inc(ALEC) | COM | 014442107 | $21.6M | 4,631,998 | 0.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $21.6M | 1,350,000 | 0.7% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $21.8M | 475,000 | 0.7% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $28.4M | 850,000 | 0.9% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $28.4M | 600,326 | 0.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $29.4M | 1,100,536 | 0.9% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $29.4M | 1,000,000 | 0.9% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $30.1M | 504,828 | 1.0% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $30.3M | 1,235,187 | 1.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $33.3M | 629,906 | 1.1% |
| Geron Corp(GERN) | COM | 374163103 | $34.4M | 7,575,049 | 1.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $38.4M | 1,963,505 | 1.2% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $40.2M | 7,065,099 | 1.3% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $40.3M | 1,725,000 | 1.3% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $41.2M | 3,579,209 | 1.3% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $44.3M | 4,096,452 | 1.4% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $46.5M | 5,576,558 | 1.5% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $47.8M | 4,000,000 | 1.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $53.6M | 1,220,508 | 1.7% |